» Articles » PMID: 32171730

Risk Factors of Bleeding in Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation

Overview
Journal Ann Thorac Surg
Publisher Elsevier
Date 2020 Mar 16
PMID 32171730
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Venoarterial extracorporeal membrane oxygenation (VA ECMO) is increasingly being used for circulatory shock. Bleeding is a frequent complication and is associated with increased mortality. The purpose of our study was to identify factors associated with early major bleeding after VA ECMO initiation.

Methods: We performed a retrospective observational study based on our database. In accordance with the Extracorporeal Life Support Organization definition, the population was divided in two groups: major bleeding events (group B) and no major bleeding events (group O). We collected data on all major bleeding events occurring during the first 48 hours after VA ECMO initiation.

Results: Of the 243 patients analyzed, 111 patients (46%) had an early major bleeding event. Independent risk factors associated with early major bleeding events were postcardiotomy VA ECMO (odds ratio [OR] 1.98; 95% confidence interval [CI], 1.08 to 3.62; P = .02), body mass index (OR 0.91; 95% CI, 0.85 to 0.98; P = .01), hemoglobinemia (OR 0.8; 95% CI, 0.7 to 0.92; P = .002), fibrinogen (OR 0.67; 95% CI, 0.52 to 0.84; P = .001), and pH (OR 0.15; 95% CI, 0.02 to 1.04; P = .05). By using a receiver-operating characteristics curve analysis, hemoglobin level less than 9 g dL, fibrinogen level less than 2 g L, pH lower than 7.12, and body mass index below 25 kg/m were identified to predict early major bleeding events. Major bleeding events were independently associated with mortality (OR 2.54; CI 95%, 1.38 to 4.66; P = .01).

Conclusions: We found that postcardiotomy VA ECMO, hemoglobin levels less than 9 g dL, fibrinogen levels less than 2 g L, pH lower than 7.12, and body mass index below 25 kg/m were associated with a higher risk for early major bleeding events.

Citing Articles

Anticoagulation and associated complications in veno-arterial extracorporeal membrane oxygenation in adult patients: A systematic review and meta-analysis.

Vlok R, Buscher H, Delaney A, Garside T, McDonald G, Chatoor R Crit Care Resusc. 2025; 26(4):332-363.

PMID: 39781486 PMC: 11704180. DOI: 10.1016/j.ccrj.2024.10.003.


Standby extracorporeal membrane oxygenation: a better strategy for high-risk percutaneous coronary intervention.

Liu C, Li X, Li J, Shen D, Sun Q, Zhao J Front Med (Lausanne). 2024; 11:1404479.

PMID: 38994335 PMC: 11238173. DOI: 10.3389/fmed.2024.1404479.


Impact of extracorporeal membrane oxygenation-related complications on in-hospital mortality.

Byun E, Kang P, Jung S, Park S, Lee S, Kwon T PLoS One. 2024; 19(3):e0300713.

PMID: 38527053 PMC: 10962856. DOI: 10.1371/journal.pone.0300713.


Definitions of major bleeding for predicting mortality in critically ill adult patients who survived 24 hours while supported with peripheral veno-arterial extracorporeal membrane oxygenation for cardiogenic shock: a comparative historical cohort....

Moussa M, Soquet J, Robin E, Labreuche J, Rousse N, Rauch A Can J Anaesth. 2024; 71(4):523-534.

PMID: 38438682 DOI: 10.1007/s12630-024-02704-6.


Risk factors for bleeding complications in patients undergoing extracorporeal cardiopulmonary resuscitation following out-of-hospital cardiac arrest: a secondary analysis of the SAVE-J II study.

Isokawa S, Hifumi T, Hirano K, Watanabe Y, Horie K, Shin K Ann Intensive Care. 2024; 14(1):16.

PMID: 38280965 PMC: 10821854. DOI: 10.1186/s13613-024-01253-x.